Introduction of Maxiliv 500mg Tablet
Maxiliv 500mg Tablet is a liver health supplement formulated to support normal liver function, protect liver cells, and promote overall liver wellness. It is commonly recommended for individuals with fatty liver, liver inflammation, elevated liver enzymes, or those requiring additional liver support due to long-term medication use, alcohol consumption, or lifestyle-related liver stress. The tablet contains liver-supporting ingredients that help improve liver function, enhance detoxification, and protect hepatocytes (liver cells) from oxidative damage.
Maxiliv 500mg Tablet may help improve appetite, digestion, and metabolism while supporting the liver’s natural ability to regenerate healthy cells. It is often used as an adjunct to medical treatment for liver disorders and should be taken under the guidance of a healthcare professional.
At Hindustan Pharmacy, we ensure genuine medicines and health supplements sourced from trusted pharmaceutical manufacturers. Whether you need liver care medications for chronic liver conditions or preventive liver health support, our team is committed to providing authentic products at competitive prices with reliable delivery across India.
Benefits of Maxiliv 500mg Tablet
- Supports healthy liver function
- Helps protect liver cells from damage
- May assist in managing fatty liver
- Promotes natural liver detoxification
- Supports healthy digestion and metabolism
- May help improve appetite and overall well-being
How to Take
Take Maxiliv Tablet exactly as prescribed by your doctor. Swallow the tablet whole with water, preferably after meals. Do not exceed the recommended dosage.
Possible Side Effects
Maxiliv Tablet is generally well tolerated. Some individuals may experience mild stomach discomfort, nausea, bloating, or diarrhea. If any unusual symptoms occur or persist, consult your doctor promptly.
Storage
Store in a cool, dry place below 25°C. Keep away from direct sunlight and moisture. Keep out of reach of children.


Reviews
There are no reviews yet.